Skip to content
Recall Observatory FDA recall evidence

Drug product

XOPENEX (levalbuterol HCl) Inhalation Solution Concentrate, 1.25mg/3mL, 0.5 mL unit-dose vials, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs

D-0856-2023

April 26, 2023

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 91788
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0856-2023

Official wording

Reason: CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Code information: All Lots

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations